Finvest vs Abridge
Side-by-side comparison of AI visibility scores, market position, and capabilities
Retail platform simplifying US Treasury Bill purchases at 0.03% fee; $2.7M from YC democratizing T-bill investing for everyday Americans competing with Public.com and brokerage accounts.
About
Finvest is a retail investing platform that democratizes US Treasury Bill investing for everyday Americans — providing a mobile app where users can purchase T-bills (yielding 5%+ in 2024) directly from the US Treasury through a streamlined process that previously required brokerage account setup and navigation of TreasuryDirect.gov's outdated interface. Founded in 2023 and a Y Combinator W23 graduate, Finvest raised $2.7 million from Bayhouse Capital and YC in January 2024, achieving $1 million in deposits within weeks of launching in December 2023.\n\nFinvest's platform makes the TreasuryDirect purchase process accessible to investors who find the government's own website confusing — the app guides users through T-bill selection (4-week, 8-week, 13-week, 26-week, 52-week maturities), provides plain-language explanations of T-bill mechanics (risk-free, US government backed, interest income state-tax exempt), and manages the purchase process with a 0.03% monthly management fee (very low compared to money market fund expense ratios). The yield-focused positioning is particularly relevant when rates are high and money market funds are competitive alternatives.\n\nIn 2025, Finvest competes with Public.com (T-bills and bonds investing), Jiko (T-bills integrated with banking), and traditional brokerage accounts (Fidelity, Schwab, where T-bills are available but not prominently featured) for the retail fixed income and cash management market. The high-yield savings and T-bill investing market grew dramatically in 2023-2024 as interest rates peaked and retail investors discovered that government securities paid more than savings accounts. As the Fed reduces rates in 2025, the relative attractiveness of T-bills vs. other savings instruments may shift. Finvest's 2025 strategy focuses on expanding the fixed income product lineup beyond T-bills (TIPS, corporate bonds, bond ETFs), growing through financial influencer and personal finance content channels, and building portfolio-level fixed income management tools.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.